Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers present novel IDO-1 inhibitor for cancer

April 25, 2018

FDA approves Jynarque to slow kidney function decline in adults with ADPKD

April 25, 2018

Takeda set to begin voluntary and conditional public takeover bid for TiGenix

April 25, 2018

Curadev Pharma targets ACSS2 for antitumor agents

April 25, 2018

Boehringer Ingelheim and Topas Therapeutics enter research agreement

April 25, 2018

First patient enrolled in phase III trial of topical ocular reproxalap

April 25, 2018

Results on sodium oxybate presented in pediatric patients with narcolepsy type 1

April 25, 2018

Third Rock Ventures launches Cedilla Therapeutics

April 25, 2018

Completion of phase I study of tozuleristide in pediatric brain tumor surgery

April 25, 2018

Nektar, Takeda to evaluate NKTR-214 in combination with TAK-659

April 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...